Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mannitol for acute traumatic brain injury.

G Schierhout1, I Roberts

  • 17 Barton Road, Greenside, Johannesburg 2193, South Africa. gillsch@mweb.co.za

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.

Journal of autoimmunity·2019
Same author

Occurrence of Tobacco streak virus on Peanut (Arachis hypogaea) in India.

Plant disease·2019
Same author

Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials.

BJOG : an international journal of obstetrics and gynaecology·2016
Same author

Road traffic injuries to children during the school commute in Hyderabad, India: cross-sectional survey.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2015
Same author

Development and validation of a self-administered questionnaire to estimate the distance and mode of children's travel to school in urban India.

BMC medical research methodology·2015
Same author

Tranexamic acid in trauma: how should we use it?

Journal of thrombosis and haemostasis : JTH·2015

Mannitol may improve mortality in severe head injury patients compared to pentobarbital. However, insufficient data exists to recommend specific mannitol regimens or pre-hospital use for traumatic brain injury management.

Area of Science:

  • Neuroscience
  • Critical Care Medicine
  • Pharmacology

Background:

  • Mannitol is used for acute brain swelling but its long-term efficacy in severe head injury is debated.
  • Concerns exist regarding mannitol crossing the blood-brain barrier and potentially increasing intracranial pressure with prolonged use.

Purpose of the Study:

  • To evaluate different mannitol therapy regimens for acute traumatic brain injury.
  • To compare mannitol with other intracranial pressure (ICP) lowering agents.
  • To assess mannitol's effectiveness at various stages post-injury.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) involving mannitol for acute traumatic brain injury.
  • Searches included reference lists and author communications.

Related Experiment Videos

  • Data extraction and quality assessment were performed independently, calculating relative risks and 95% confidence intervals.

    • Main Results:

    • Few eligible trials were identified; no trials compared different mannitol doses or administration types.
    • One trial suggested a potential mortality benefit of mannitol over pentobarbital (RR 0.85; 95% CI 0.52-1.38).
    • ICP-directed therapy showed a slight benefit over standard care (RR 0.83; 95% CI 0.47-1.46).

    Conclusions:

    • Insufficient evidence exists to recommend specific mannitol infusion protocols.
    • Mannitol may offer a mortality benefit compared to pentobarbital for elevated ICP.
    • Limited data prevents definitive conclusions on pre-hospital mannitol administration's safety or efficacy.